advanced cancer

You have access
Efficacy of a Flat Low Dose of Nivolumab in Advanced Cancer: A Retrospective Case Series
SOFIE JORIS, CHRISTEL FONTAINE, LORE DECOSTER, JACQUES VANDERAUWERA, KRIS THIELEMANS, WIM WAELPUT and JACQUES DE-GRÈVE

Anticancer Research March 2022, 42 (3) 1433-1437; DOI: https://doi.org/10.21873/anticanres.15613
You have access
Objective Predictive Score as a Feasible Biomarker for Short-term Survival in TerminalIy Ill Patients with Cancer
YOSHINAGA OKUGAWA, YUMIKO SHIRAI, HIROKO NODONO, FUKUMI MATSUTANI, MARI ITOH, ASAHI HISHIDA, YUKI MORIMOTO, RYUTARO NISHIKAWA, TAKESHI YOKOE, KOJI TANAKA, HISASHI URATA, YUJI TOIYAMA, TOSHIMITSU ARAKI, YASUHIRO INOUE, MOTOYOSHI TANAKA, MASATO KUSUNOKI and CHIKAO MIKI

Anticancer Research January 2017, 37 (1) 267-275;
You have access
Metabolic Treatment of Cancer: Intermediate Results of a Prospective Case Series
LAURENT SCHWARTZ, LUDIVINE BUHLER, PHILIPPE ICARD, HUBERT LINCET and JEAN-MARC STEYAERT

Anticancer Research February 2014, 34 (2) 973-980;
You have access
Improved Quality of Life in Patients with Malignant Pleural Effusion Following Videoassisted Thoracoscopic Talc Pleurodesis. Preliminary Results
STEFANO M.M. BASSO, FRANCESCO MAZZA, BERNARDO MARZANO, DAVIDE A. SANTEUFEMIA, GIORDANO B. CHIARA and FRANCO LUMACHI

Anticancer Research November 2012, 32 (11) 5131-5134;

Main menu